AstraZeneca PLC (AZN)
75.03
+3.83
(+5.38%)
USD |
NASDAQ |
Apr 25, 16:00
75.27
+0.24
(+0.32%)
After-Hours: 04:33
AstraZeneca Price: 75.03 for April 25, 2024
Price Chart
Historical Price Data
Date | Open | High | Low | Close | Volume |
---|---|---|---|---|---|
Apr 25, 2024 | 74.99 | 75.81 | 74.50 | 75.03 | 15.55M |
Apr 24, 2024 | 71.41 | 71.47 | 70.68 | 71.20 | 6.138M |
Apr 23, 2024 | 70.43 | 71.10 | 70.16 | 70.85 | 5.806M |
Apr 22, 2024 | 69.67 | 70.49 | 69.38 | 70.13 | 5.184M |
Apr 19, 2024 | 68.14 | 68.71 | 68.13 | 68.55 | 4.736M |
Apr 18, 2024 | 68.25 | 68.78 | 68.16 | 68.36 | 4.006M |
Apr 17, 2024 | 68.72 | 68.80 | 68.20 | 68.53 | 3.710M |
Apr 16, 2024 | 68.29 | 68.60 | 68.02 | 68.26 | 5.362M |
Apr 15, 2024 | 69.07 | 69.56 | 68.54 | 68.73 | 9.214M |
Apr 12, 2024 | 69.66 | 69.82 | 68.60 | 68.93 | 9.121M |
Apr 11, 2024 | 69.88 | 70.07 | 68.87 | 69.45 | 5.986M |
Apr 10, 2024 | 67.59 | 68.16 | 67.42 | 68.11 | 7.716M |
Apr 09, 2024 | 68.20 | 68.46 | 67.96 | 68.41 | 4.393M |
Apr 08, 2024 | 67.57 | 67.77 | 67.22 | 67.70 | 3.825M |
Apr 05, 2024 | 66.98 | 67.72 | 66.89 | 67.45 | 4.811M |
Apr 04, 2024 | 68.99 | 68.99 | 67.29 | 67.34 | 7.454M |
Apr 03, 2024 | 66.40 | 67.35 | 66.38 | 66.81 | 3.796M |
Apr 02, 2024 | 67.15 | 67.38 | 66.76 | 67.00 | 4.397M |
Apr 01, 2024 | 68.20 | 68.22 | 67.04 | 67.25 | 3.114M |
Mar 28, 2024 | 68.18 | 68.35 | 67.68 | 67.75 | 3.617M |
Mar 27, 2024 | 67.08 | 68.38 | 67.06 | 68.26 | 8.444M |
Mar 26, 2024 | 66.25 | 66.46 | 65.76 | 66.33 | 3.133M |
Mar 25, 2024 | 66.21 | 66.43 | 65.80 | 65.86 | 4.425M |
Mar 22, 2024 | 66.49 | 66.84 | 66.20 | 66.26 | 4.099M |
Mar 21, 2024 | 66.61 | 66.79 | 66.18 | 66.19 | 5.352M |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
37.28
Minimum
May 13 2019
75.81
Maximum
Apr 24 2023
57.94
Average
57.96
Median
Jul 22 2021
Price Benchmarks
GSK PLC | 40.91 |
Amgen Inc | 269.38 |
Sanofi SA | 49.36 |
Viking Therapeutics Inc | 68.86 |
Fusion Pharmaceuticals Inc | 21.40 |
Price Related Metrics
PE Ratio | 39.18 |
PS Ratio | 5.116 |
PEG Ratio | 0.4806 |
Price to Book Value | 5.943 |
Price to Free Cash Flow | 35.69 |
Earnings Yield | 2.55% |
Market Cap | 232.62B |
PEGY Ratio | 0.4695 |
Operating PE Ratio | 26.87 |
Normalized PE Ratio | 36.75 |